Cargando…
Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion
BACKGROUND: Recent studies have demonstrated that blocking the PI3Kδ signalling enzyme (by administering a small molecule inhibitor, PI-3065) can potently improve the anti-tumour T-cell response through direct inhibition of Tregs. This treatment also has a negative impact on MDSC numbers but the pri...
Autores principales: | Lauder, Sarah N., Smart, Kathryn, Bart, Valentina M. T., Pires, Ana, Scott, Jake, Milutinovic, Stefan, Godkin, Andrew, Vanhaesebroeck, Bart, Gallimore, Awen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596434/ https://www.ncbi.nlm.nih.gov/pubmed/35986086 http://dx.doi.org/10.1038/s41416-022-01917-0 |
Ejemplares similares
-
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach
por: Lauder, Sarah N., et al.
Publicado: (2021) -
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
por: Lauder, Sarah Nicol, et al.
Publicado: (2020) -
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion
por: Hughes, Ellyn, et al.
Publicado: (2020) -
The link between T cell activation and development of functionally useful tumour-associated high endothelial venules
por: Milutinovic, Stefan, et al.
Publicado: (2023) -
Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T Cells
por: Milutinovic, Stefan, et al.
Publicado: (2022)